Xeris Biopharma Reports Third Quarter 2024 Financial Results

Go back to Xeris Biopharma Reports Third Quarter 2024 Financial Results
(NASDAQ: XERS) Delayed: 8.60 -0.18 (2.05%)
Previous Close $8.78    52 Week High
Open $8.91    52 Week Low
Day High $8.99    P/E N/A 
Day Low $8.56    EPS
Volume 2,001,198